P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110 Por P. Hengeveld, Y. E. Ertem, J. Dubois, C. Mellink, A.-M. van der Kevie-Kersemaekers, L. Evers, K. Heezen, P. M. Kolijn, O. Mook, M. M. Motazacker, K. Nasserinejad, S. Kersting, P. Westerweel, C. Niemann, A. Kater, A. Langerak, M.-D. Levin

Obter o texto integral